These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 31637490)

  • 21. An iPSC model for POLR3A-associated spastic ataxia: Generation of three unrelated patient cell lines.
    Manibarathi K; Pham T; Hengel H; Synofzik M; Nagel M; Schüle R
    Stem Cell Res; 2024 Apr; 76():103363. PubMed ID: 38437768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multimodal evaluation of an Italian family with a hereditary spastic paraplegia and POLR3A mutations.
    Ruggiero L; Iovino A; Dubbioso R; Cocozza S; Trovato R; Aruta F; Pontillo G; Barghigiani M; Brunetti A; Santorelli FM; Manganelli F; Iodice R
    Ann Clin Transl Neurol; 2020 Nov; 7(11):2326-2331. PubMed ID: 33085208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Diagnostic Approach to Spastic ataxia Syndromes.
    Pedroso JL; Vale TC; França Junior MC; Kauffman MA; Teive H; Barsottini OGP; Munhoz RP
    Cerebellum; 2022 Dec; 21(6):1073-1084. PubMed ID: 34782953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spastic paraplegia type 46: novel and recurrent GBA2 gene variants in a compound heterozygous Italian patient with spastic ataxia phenotype.
    Gatti M; Magri S; Di Bella D; Sarto E; Taroni F; Mariotti C; Nanetti L
    Neurol Sci; 2021 Nov; 42(11):4741-4745. PubMed ID: 34251556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two cases of early-onset autosomal recessive spastic ataxia of Charlevoix-Saguenay diagnosed in adulthood.
    Sahin T; Karaarslan FT; Yilmaz R; Tekgül Ş; Başak AN; Akbostanci MC
    Clin Neurol Neurosurg; 2021 Feb; 201():106423. PubMed ID: 33348119
    [No Abstract]   [Full Text] [Related]  

  • 26. Expanding the clinical and neuroimaging features of NKX6-2-related hereditary spastic ataxia type 8.
    Hosseini Bereshneh A; Hosseipour S; Rasoulinezhad MS; Pak N; Garshasbi M; Tavasoli AR
    Eur J Med Genet; 2020 May; 63(5):103868. PubMed ID: 32004679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination.
    Chelban V; Patel N; Vandrovcova J; Zanetti MN; Lynch DS; Ryten M; Botía JA; Bello O; Tribollet E; Efthymiou S; Davagnanam I; ; Bashiri FA; Wood NW; Rothman JE; Alkuraya FS; Houlden H
    Am J Hum Genet; 2017 Jun; 100(6):969-977. PubMed ID: 28575651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel CAPN1 mutations extend the phenotypic heterogeneity in combined spastic paraplegia and ataxia.
    Lai LL; Chen YJ; Li YL; Lin XH; Wang MW; Dong EL; Wang N; Chen WJ; Lin X
    Ann Clin Transl Neurol; 2020 Oct; 7(10):1862-1869. PubMed ID: 32860341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recessive null-allele variants in MAG associated with spastic ataxia, nystagmus, neuropathy, and dystonia.
    Zech M; Brunet T; Škorvánek M; Blaschek A; Vill K; Hanker B; Hüning I; Haň V; Došekova P; Gdovinová Z; Alhaddad B; Berutti R; Strom TM; Růžička E; Kamsteeg EJ; van der Smagt JJ; Wagner M; Jech R; Winkelmann J
    Parkinsonism Relat Disord; 2020 Aug; 77():70-75. PubMed ID: 32629324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a novel homozygous SPG7 mutation in a Japanese patient with spastic ataxia: making an efficient diagnosis using exome sequencing for autosomal recessive cerebellar ataxia and spastic paraplegia.
    Doi H; Ohba C; Tsurusaki Y; Miyatake S; Miyake N; Saitsu H; Kawamoto Y; Yoshida T; Koyano S; Suzuki Y; Kuroiwa Y; Tanaka F; Matsumoto N
    Intern Med; 2013; 52(14):1629-33. PubMed ID: 23857099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. POLR3A-related disorders: From spastic ataxia to generalised dystonia and long-term efficacy of deep brain stimulation.
    Yau WY; Ashton C; Mulroy E; Foltynie T; Limousin P; Vandrovcova J; Verma KP; Stell R; Davis M; Lamont P
    Ann Clin Transl Neurol; 2024 Jun; 11(6):1636-1642. PubMed ID: 38700104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spastic ataxias.
    Bereznyakova O; Dupré N
    Handb Clin Neurol; 2018; 155():191-203. PubMed ID: 29891058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biallelic POLR3A variants confirmed as a frequent cause of hereditary ataxia and spastic paraparesis.
    Rydning SL; Koht J; Sheng Y; Sowa P; Hjorthaug HS; Wedding IM; Erichsen AK; Hovden IA; Backe PH; Tallaksen CME; Vigeland MD; Selmer KK
    Brain; 2019 Apr; 142(4):e12. PubMed ID: 30847471
    [No Abstract]   [Full Text] [Related]  

  • 34. Reply: Biallelic POLR3A variants confirmed as a frequent cause of hereditary ataxia and spastic paraparesis.
    Minnerop M; Kurzwelly D; Wagner H; Schüle R; Ramirez A
    Brain; 2019 Apr; 142(4):e13. PubMed ID: 30847463
    [No Abstract]   [Full Text] [Related]  

  • 35. Subtle Imaging Findings Aid the Diagnosis of Adolescent Hereditary Spastic Paraplegia and Ataxia.
    Wagner F; Titelbaum DS; Engisch R; Coskun EK; Waugh JL
    Clin Neuroradiol; 2019 Jun; 29(2):215-221. PubMed ID: 29379980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary Myelopathies.
    Hedera P
    Continuum (Minneap Minn); 2018 Apr; 24(2, Spinal Cord Disorders):523-550. PubMed ID: 29613898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel compound heterozygous SPG7 variant is associated with progressive spastic ataxia and persecutory delusions found in Chinese patients: two case reports.
    Wang S; Wang Y; Wu Y; Zhang J; Zhang W; Li C; Song X
    BMC Neurol; 2022 May; 22(1):200. PubMed ID: 35637455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A homozygous missense variant in the homeobox domain of the NKX6-2 results in progressive spastic ataxia type 8 associated with lower limb weakness and neurological manifestations.
    Almatrafi A; Umair M; Eldardear A; Al-Luqmani M; Hashmi JA; Albalawi AM; Alfadhel M; Ramzan K; Basit S
    J Gene Med; 2020 Aug; 22(8):e3196. PubMed ID: 32246862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy.
    Park J; Tucci A; Cipriani V; Demidov G; Rocca C; Senderek J; Butryn M; Velic A; Lam T; Galanaki E; Cali E; Vestito L; Maroofian R; Deininger N; Rautenberg M; Admard J; Hahn GA; Bartels C; van Os NJH; Horvath R; Chinnery PF; Tiet MY; Hewamadduma C; Hadjivassiliou M; Tofaris GK; ; Wood NW; Hayer SN; Bender F; Menden B; Cordts I; Klein K; Nguyen HP; Krauss JK; Blahak C; Strom TM; Sturm M; van de Warrenburg B; Lerche H; Maček B; Synofzik M; Ossowski S; Timmann D; Wolf ME; Smedley D; Riess O; Schöls L; Houlden H; Haack TB; Hengel H
    Genet Med; 2022 Oct; 24(10):2079-2090. PubMed ID: 35986737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-exome sequencing confirms implication of VPS13D as a potential cause of progressive spastic ataxia.
    Durand CM; Angelini C; Michaud V; Delleci C; Coupry I; Goizet C; Trimouille A
    BMC Neurol; 2022 Feb; 22(1):53. PubMed ID: 35151251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.